MedTrace Logo

Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity

NCT05807204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-02-23

No results posted yet for this study

Summary

The aim of this study is to validate the efficacy of specific combination of different natural histidine-related amino acids in the reduction of visceral fat and liver steatosis, as well their associated comorbidities, in individuals with abdominal obesity.

Conditions

  • Visceral Obesity
  • Non-Alcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT

Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

DIETARY_SUPPLEMENT

Placebo

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

Sponsors & Collaborators

  • Centre de Diagnosi per la Imatge

    collaborator UNKNOWN

  • Laboratorio de Referencia Sud

    collaborator UNKNOWN

  • Centro OWLiver

    collaborator UNKNOWN

  • Fundació Eurecat

    lead OTHER

Principal Investigators

  • Xavier Escoté, PhD · Eurecat, Technology Centre of Catalonia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-12-20
Completion
2024-01-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05807204 on ClinicalTrials.gov